Literature DB >> 30644946

In vitro cytotoxicity of a library of BODIPY-anthracene and -pyrene dyads for application in photodynamic therapy.

Susan Callaghan1, Mikhail A Filatov1, Huguette Savoie2, Ross W Boyle3, Mathias O Senge4.   

Abstract

The facile synthesis and in vitro activity of a library of heavy atom-free BODIPY-anthracene, -pyrene dyads (BAD-13-BPyrD-19) and a control (BODIPY 20) are reported. We demonstrate that singlet oxygen produced from dyad triplet states formed from charge-separated states is sufficient to induce cytotoxicity in human breast cancer cells (MDA-MB-468) at micromolar concentrations. The compounds in this series are promising candidates for photodynamic therapy, especially BAD-17 which displays significant photocytotoxicity (15% cell viability) at a concentration of 5 × 10-7 M, with minimal toxicity (89% cell viability) in the absence of light.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30644946     DOI: 10.1039/c8pp00402a

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  3 in total

1.  Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers.

Authors:  Kelly A D F Castro; Letícia D Costa; Samuel Guieu; Juliana C Biazzotto; Maria Graça P M S da Neves; M Amparo F Faustino; Roberto S da Silva; Augusto C Tomé
Journal:  Photochem Photobiol Sci       Date:  2020-06-17       Impact factor: 3.982

2.  BODIPY nanoparticles functionalized with lactose for cancer-targeted and fluorescence imaging-guided photodynamic therapy.

Authors:  Duy Khuong Mai; Chanwoo Kim; Joomin Lee; Temmy Pegarro Vales; Isabel Wen Badon; Koushitak De; Sung Cho; Jaesung Yang; Ho-Joong Kim
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

3.  Delivering Singlet Oxygen in Dark Condition With an Anthracene-Functionalized Semiconducting Compound for Enhanced Phototheranostics.

Authors:  Jian Shen; Liuhong Pan; Xujing Zhang; Zhenyuan Zou; Bo Wei; Yongchang Chen; Xiaoyan Tang; Dengfeng Zou
Journal:  Front Bioeng Biotechnol       Date:  2022-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.